Activity of the MEK inhibitor trametinib in a patient with a <i>BRAF</i> mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia

Published:2024-03-26 Issue:6 Volume:71 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Bourgeois Wallace¹^ORCID,Yang Edward²,Chiarle Roberto³⁴⁵,Burns Melissa¹^ORCID

Affiliation:

1. Department of Pediatric Oncology Dana‐Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School Boston Massachusetts USA

2. Department of Radiology Boston Children's Hospital and Harvard Medical School Boston Massachusetts USA

3. Department of Pathology Boston Children's Hospital and Harvard Medical School Boston Massachusetts USA

4. Division of Haematopathology European Institute of Oncology IRCCS Milan Italy

5. Hematopathology division IRCCS Istituto Europeo di Oncologia Milan Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30978

Reference17 articles.

1. Genomic Classification and Prognosis in Acute Myeloid Leukemia

2. BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias

3. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities

4. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP